Amgen Sues Coherus Over Chemo Drug Trade Secrets
Amgen Inc. on Friday sued Coherus Biosciences Inc., which is seeking approval of a biosimilar of Amgen's chemotherapy drug Neulasta, telling a California court that Coherus has been poaching its employees...To view the full article, register now.
Already a subscriber? Click here to view full article